China Universal Asset Management Co., Ltd. Castle Biosciences Inc Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Castle Biosciences Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 5,297 shares of CSTL stock, worth $112,614. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,297
Previous 5,297
-0.0%
Holding current value
$112,614
Previous $117,000
-0.0%
% of portfolio
0.02%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding CSTL
# of Institutions
162Shares Held
25.3MCall Options Held
82.2KPut Options Held
150K-
Black Rock Inc. New York, NY2.6MShares$55.2 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT2.55MShares$54.2 Million0.3% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.63MShares$34.6 Million1.3% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.53MShares$32.6 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.49MShares$31.8 Million0.0% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $559M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...